Erin Sauve
@erinsauve.bsky.social
PhD candidate working on vivax malaria and drug resistance at @itmmalaria.bsky.social 🦠🦟🔬 | Returned PeaceCorps Volunteer - Madagascar 🇲🇬
Many thanks to our team that made it all possible and the editor and peer reviewers for their time and feedback!
July 7, 2025 at 1:29 PM
Many thanks to our team that made it all possible and the editor and peer reviewers for their time and feedback!
Dr. Katherine Jessica Torres Fajardo ended Session 6 with a turbo talk on the antibody signatures of P. vivax infections from the Peruvian Amazon
February 13, 2025 at 9:12 AM
Dr. Katherine Jessica Torres Fajardo ended Session 6 with a turbo talk on the antibody signatures of P. vivax infections from the Peruvian Amazon
Léa Baldor closed the session with PvDBP gene amplification and how this can be a protection mechanism against naturally acquired anti-PvDBP immunity.
February 13, 2025 at 6:45 AM
Léa Baldor closed the session with PvDBP gene amplification and how this can be a protection mechanism against naturally acquired anti-PvDBP immunity.
Dr. Maisa Araujo shared how transmission blocking is possible using atovaquone treated sugar feed in Anopheles darlingi females infected with P. vivax.
February 13, 2025 at 6:45 AM
Dr. Maisa Araujo shared how transmission blocking is possible using atovaquone treated sugar feed in Anopheles darlingi females infected with P. vivax.
February 13, 2025 at 5:52 AM
Dr. Carmen Fernandez-Becerra shares her work on cryptic P. vivax infections and extracellular vesicles as intracellulair communicators, with some beautiful images and single-cell spleen fibroblast data! EVs have great potential for novel biomarker discovery as well!
February 13, 2025 at 5:51 AM
Dr. Carmen Fernandez-Becerra shares her work on cryptic P. vivax infections and extracellular vesicles as intracellulair communicators, with some beautiful images and single-cell spleen fibroblast data! EVs have great potential for novel biomarker discovery as well!
Next, Dr. Vaneeta Singh presented on the prevalence of molecular markers in P. vivax in India. For the putative drug resistance markers, pvmdr1 was predominantly the MLL triple mutant and all pvcrt was wildtype.
February 13, 2025 at 5:51 AM
Next, Dr. Vaneeta Singh presented on the prevalence of molecular markers in P. vivax in India. For the putative drug resistance markers, pvmdr1 was predominantly the MLL triple mutant and all pvcrt was wildtype.
Finally, our own Dalia Diaz-Delgado (daliia193.bsky.social) gave a fantastic turbo talk on a new set of P. knowlesi biomarkers from a Pk time course and compared Pk and Pv gene expression. (4/4)
February 12, 2025 at 8:26 PM
Finally, our own Dalia Diaz-Delgado (daliia193.bsky.social) gave a fantastic turbo talk on a new set of P. knowlesi biomarkers from a Pk time course and compared Pk and Pv gene expression. (4/4)
Dr. Usheer Kanjee used CRISPR/Cas9 knockouts and RNAi knockdowns to characterize the functional role of Band3 in invasion. (3/4)
February 12, 2025 at 8:26 PM
Dr. Usheer Kanjee used CRISPR/Cas9 knockouts and RNAi knockdowns to characterize the functional role of Band3 in invasion. (3/4)
Dr. Maria Ome Kaius shared the exciting advances and safety/feasibility of a point-of-care G6PD deficiency testing which is part of a revised case management package! (2/4)
February 12, 2025 at 8:26 PM
Dr. Maria Ome Kaius shared the exciting advances and safety/feasibility of a point-of-care G6PD deficiency testing which is part of a revised case management package! (2/4)